PFF Walk series launched to raise funds and awareness for pulmonary fibrosis and interstitial lung disease

NewsGuard 100/100 Score

The Pulmonary Fibrosis Foundation (PFF) today announced the launch of its annual PFF Walk series, a nationwide effort to raise funds and awareness for pulmonary fibrosis (PF) and interstitial lung disease (ILD). More than 250,000 Americans are living with PF and ILD, progressive diseases that cause inflammation, scarring, or both, that damage the lung's ability to absorb oxygen from the air.

The PFF Walk will kick off on July 29 in Pittsburgh and will continue through October in cities across the U.S. -;

• Jul. 29 – North Shore Riverfront Park, Pittsburgh
• Aug. 5 – Liberty State Park, NYC Metro
• Sept. 9 – Little Marina Green, Bay Area
• Sept. 16 – Diversey Harbor, Chicago
• Sept. 30 – Virtual, National Walk Day
• Oct. 7 – National Harbor, Washington, D.C.
• Oct. 21 – The Sound at Cypress Waters, Dallas

The PFF Walk is a growing movement that inspires and empowers those whose lives have been affected by these debilitating diseases. Participants are energized by the opportunity to make a difference by fundraising and sharing their experiences with PF and ILD."

William T. Schmidt, President, and CEO of the PFF

The PFF Walk is a memorable experience and brings together people living with PF, caregivers and families, lung transplant recipients, and all community members. New this year, each Walk will include a Mission Moment that honors all attendees and provides a moment of remembrance for those who have been lost to pulmonary fibrosis.

Each Walk features two course options – 5K and one mile. Participants are encouraged to go at their own pace. The event will also include a variety of activities and entertainment, including music, food, and family fun.

Registration for the PFF Walk is free. Walkers who raise $100 or more will receive a commemorative PFF Walk t-shirt. To register or for more information, visit PFFWalk.org. A special thank you to the PFF Walk National Sponsors, Boehringer Ingelheim, CVS Specialty Pharmacy, Horizon Therapeutics and United Therapeutics.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
UVA scientists develop new approach to machine learning for identifying heart drug